Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lineage Cell Therapeutics, Inc. (LCTX)
USD1.23
+0.00 (+0.00%)
US AMEX Healthcare Biotechnology
Address
2173 Salk Avenue 92008
Carlsbad, CA, US
Carlsbad, CA, US
CEO
Brian Culley
Website
lineagecell.com
IPO
1992-03-05
CIK 876343 ISIN US53566P1093
Also trades on
New York Stock Exchange American · LCTX (USD)
Tel Aviv Stock Exchange · LCTX.TA (ILA)
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; and OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries. It also offers ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of sensorineural hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company is developing RND1, a novel hypoimmune induced pluripotent stem cell line for the development of a cell transplant candidate for the potential treatment of an undisclosed indication, as well as engages in the research and development of ILT1, an allogeneic cell transplant for the treatment of Type 1 Diabetes; and LCT-CON, an allogeneic cell transplant, as well as therapeutic products for retinal diseases, neurological diseases, ophthalmology, metabolic, and disorders and oncology. The company has a collaboration agreement with William Demant Invest for the preclinical development of ReSonance (ANP1). It also has a strategic collaboration with Factor Bioscience Inc. for the development of genetically engineered iPSC line for the company to utilize for differentiation into certain cell transplant product candidates. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Eterna Therapeutics Inc. | BTX | 2019-01-04 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.23
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.51
Float Shares
236.33M
Free Float %
94.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.53% | -3.62% | -11.92% | -19.88% | -26.11% | -20.36% | +182.98% | -4.32% | -38.71% | -48.45% | -66.04% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
1.23
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-3.34
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+53.2% ★ Q1'26: +14.8% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-201.1% Q1'26: -63.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-141.5% Q1'26: -468.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-149.6% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+15.0% Q1'26: +15.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.11× Q1'26: -0.08× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 7 Rev. Ana. 6 EPS Ana. |
Dec 2029 3 Rev. Ana. 4 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.53M
est: 6.68M (-62.1%)
|
2.25M
est: 4.99M (-54.8%)
|
1.79M
est: 3.38M (-47.0%)
|
1.42M
est: 4.90M (-71.1%)
|
1.48M
est: 3.31M (-55.3%)
|
773.0K
est: 2.40M (-67.8%)
|
3.90M
est: 4.01M (-2.9%)
|
14.70M
est: 15.35M (-4.2%)
|
8.95M
est: 6.19M (+44.6%)
|
9.50M
est: 8.18M (+16.2%)
|
14.56M
est: 9.90M (+47.0%)
|
22.33M
9.87M – 35.11M
+125.5% YoY
|
14.71M
3.59M – 31.92M
-34.2% YoY
|
46.62M
44.20M – 49.04M
+217.0% YoY
|
103.18M
32.46M – 201.97M
+121.3% YoY
|
369.37M
116.21M – 723.02M
+258.0% YoY
|
| EBITDA |
-59.48M
est: -6.68M (-790.3%)
|
-54.21M
est: -4.99M (-987.2%)
|
-37.36M
est: -3.38M (-1,004.2%)
|
-37.72M
est: -4.90M (-670.1%)
|
-35.88M
est: -3.31M (-983.9%)
|
-24.41M
est: -2.40M (-917.1%)
|
-48.34M
est: -4.01M (-1,105.1%)
|
-21.79M
est: -17.74M (-22.8%)
|
-24.04M
est: -6.19M (-288.6%)
|
-20.87M
est: -8.18M (-155.3%)
|
-21.08M
est: -9.90M (-112.9%)
|
-22.33M
-35.11M – -9.87M
-125.5% YoY
|
-14.71M
-31.92M – -3.59M
+34.2% YoY
|
-46.62M
-49.04M – -44.20M
-217.0% YoY
|
-103.18M
-201.97M – -32.46M
-121.3% YoY
|
-369.37M
-723.02M – -116.21M
-258.0% YoY
|
| EBIT |
-65.81M
est: -6.68M (-885.2%)
|
-58.97M
est: -4.99M (-1,082.7%)
|
-40.66M
est: -3.38M (-1,101.6%)
|
-41.00M
est: -4.90M (-736.9%)
|
-38.88M
est: -3.31M (-1,074.6%)
|
-26.45M
est: -2.40M (-1,002.1%)
|
-49.21M
est: -4.01M (-1,126.8%)
|
-22.52M
est: -17.83M (-26.3%)
|
-24.73M
est: -6.19M (-299.8%)
|
-21.48M
est: -8.18M (-162.7%)
|
-21.78M
est: -9.90M (-120.0%)
|
-22.33M
-35.11M – -9.87M
-125.5% YoY
|
-14.71M
-31.92M – -3.59M
+34.2% YoY
|
-46.62M
-49.04M – -44.20M
-217.0% YoY
|
-103.18M
-201.97M – -32.46M
-121.3% YoY
|
-369.37M
-723.02M – -116.21M
-258.0% YoY
|
| Net Income |
-46.99M
est: -110.65M (+57.5%)
|
33.57M
est: 41.84M (-19.8%)
|
-19.98M
est: 63.23M (-131.6%)
|
-45.99M
est: -25.42M (-80.9%)
|
-11.71M
est: -24.52M (+52.3%)
|
-20.65M
est: -39.70M (+48.0%)
|
-43.02M
est: -31.70M (-35.7%)
|
-26.27M
est: -22.02M (-19.3%)
|
-21.49M
est: -24.19M (+11.2%)
|
-18.61M
est: -12.98M (-43.4%)
|
-63.53M
est: -63.53M (+0.0%)
|
-15.28M
-19.78M – -10.79M
+75.9% YoY
|
-23.09M
-37.97M – 7.59M
-51.1% YoY
|
3.08M
-32.22M – 110.46M
+113.3% YoY
|
38.20M
4.16M – 85.75M
+1,139.5% YoY
|
266.36M
29.03M – 597.89M
+597.3% YoY
|
| SGA |
29.13M
est: 40.34M (-27.8%)
|
28.43M
est: 30.11M (-5.6%)
|
19.92M
est: 20.43M (-2.5%)
|
24.73M
est: 29.58M (-16.4%)
|
24.03M
est: 19.99M (+20.2%)
|
15.57M
est: 14.49M (+7.4%)
|
18.21M
est: 24.22M (-24.8%)
|
22.51M
est: 15.09M (+49.1%)
|
17.30M
est: 14.01M (+23.5%)
|
18.17M
est: 18.51M (-1.8%)
|
18.46M
est: 22.42M (-17.7%)
|
50.57M
22.34M – 79.51M
+125.5% YoY
|
33.30M
8.13M – 72.26M
-34.2% YoY
|
105.55M
100.07M – 111.03M
+217.0% YoY
|
233.61M
73.50M – 457.29M
+121.3% YoY
|
836.31M
263.11M – 1.64B
+258.0% YoY
|
| EPS |
-0.59
est: -0.55 (-6.7%)
|
0.35
est: 0.21 (+67.5%)
|
-0.17
est: 0.32 (-153.8%)
|
-0.36
est: -0.13 (-183.5%)
|
-0.08
est: -0.12 (+33.6%)
|
-0.14
est: -0.20 (+29.4%)
|
-0.26
est: -0.16 (-64.2%)
|
-0.15
est: -0.15 (+0.9%)
|
-0.12
est: -0.13 (+10.5%)
|
-0.09
est: -0.06 (-64.9%)
|
-0.28
est: -0.30 (+5.3%)
|
-0.06
-0.09 – -0.05
+78.9% YoY
|
-0.08
-0.17 – 0.03
-32.0% YoY
|
-0.01
-0.14 – 0.48
+87.9% YoY
|
0.17
0.02 – 0.37
+1,760.0% YoY
|
1.16
0.13 – 2.60
+597.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-04 | D. Boral Capital | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-15.56M
OE per share TTM
-0.07
Owner's Yield
-5.16%
Maintenance CapEx ratio
298.79%
Maint CapEx / Avg PPE
71.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
42
Total invested
22.74M
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 9.92M | 5.30% | 9.88M | — | 9.92M | — | HC | Delaware | 2024-11-08 | ↗ |
| 2 | ALFRED D. KINGSLEY | 5.70M | 3.62% | — | — | — | — | IN | — | 2020-02-14 | ↗ |
| 3 | George Karfunkel. | 4.70M | 15.40% | 4.70M | — | 4.70M | — | IN | United States | 2009-07-14 | ↗ |
| 4 | GARY K. DUBERSTEIN | 2.78M | 12.00% | — | — | — | — | IN | : | 2005-12-28 | ↗ |
| 5 | (entities only): ** | 2.34M | 9.90% | 2.34M | — | 2.34M | 10.00 | IN | United | 2006-01-11 | ↗ |
| 6 | : George Karfunkel. | 2.34M | 9.80% | 2.34M | — | 2.34M | — | IN | United States | 2006-04-20 | ↗ |
| 7 | GREENBELT CORP. | 1.97M | 3.90% | 1.97M | — | 1.97M | — | CO | Delaware | 2012-07-31 | ↗ |
| 8 | 13-3791931 | 1.79M | 7.90% | — | — | — | — | CO | : | 2005-12-28 | ↗ |
| 9 | GREENBROOK VALLEY LLC | 976.1K | 4.30% | — | — | — | — | OO | : | 2005-12-28 | ↗ |
| 10 | GREENMINT LLC | 976.1K | 4.30% | — | — | — | — | OO | : | 2005-12-28 | ↗ |
| 11 | 04-2601915 | 502.4K | 5.11% | 402.3K | — | 502.4K | — | IA | MASSACHUSETTS | 1998-01-29 | ↗ |
| 12 | GREENWAY PARTNERS, L.P. | 375.4K | 0.25% | — | — | — | — | PN | — | 2020-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
42
-83 vs prev Q
New positions
3
Closed positions
82
Increased
10
Reduced
4
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 216.0K +216.0K (+100.0%) | 360.72M +360.7M (+100.0%) | 0.09% +0.094 pp | 0.04% +0.043 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 2 | BROADWOOD CAPITAL INC | 49.56M +— (+0.0%) | 82.77M -991.2K (-1.2%) | 21.66% -0.047 pp | 4.86% -0.179 pp | USD0.97 +72.2% | 26 qtrs — |
| 3 | VANGUARD GROUP INC | 9.64M +637.3K (+7.1%) | 16.11M +884.2K (+5.8%) | 4.21% +0.270 pp | 0.00% +0.000 pp | USD1.33 +25.6% | 26 qtrs — |
| 4 | DEFENDER CAPITAL, LLC. | 6.83M +6.8M (+100.0%) | 11.41M +11.4M (+100.0%) | 2.98% +2.984 pp | 3.70% +3.695 pp | USD1.67 +0.0% | 26 qtrs — |
| 5 | RAFFLES ASSOCIATES LP | 5.36M -25.0K (-0.5%) | 8.96M -149.5K (-1.6%) | 2.34% -0.016 pp | 6.72% -1.759 pp | USD1.19 +40.3% | 20 qtrs — |
| 6 | COMERICA BANK | 4.60M +— (+0.0%) | 7.68M -92.0K (-1.2%) | 2.01% -0.004 pp | 0.03% +0.001 pp | USD0.67 +149.3% | 10 qtrs — |
| 7 | BLACKROCK, INC. | 3.83M +1.6M (+71.9%) | 6.40M +2.6M (+69.8%) | 1.68% +0.699 pp | 0.00% +0.000 pp | USD1.19 +40.3% | 6 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.46M +41.4K (+1.7%) | 4.11M +20.7K (+0.5%) | 1.08% +0.016 pp | 0.00% +0.000 pp | USD1.33 +25.6% | 26 qtrs — |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 2.40M +499.2K (+26.2%) | 4.02M +795.5K (+24.7%) | 1.05% +0.216 pp | 0.01% +0.002 pp | USD0.80 +108.8% | 11 qtrs — |
| 10 | MILLENNIUM MANAGEMENT LLC | 2.11M -569.6K (-21.3%) | 3.52M -1.0M (-22.2%) | 0.92% -0.251 pp | 0.00% -0.001 pp | USD0.93 +79.6% | 3 qtrs — |
| 11 | MORGAN STANLEY | 2.00M +992.2K (+98.6%) | 3.34M +1.6M (+96.2%) | 0.87% +0.433 pp | 0.00% +0.000 pp | USD1.35 +23.7% | 26 qtrs — |
| 12 | GOLDMAN SACHS GROUP INC | 1.44M +1.3M (+894.5%) | 2.40M +2.2M (+882.7%) | 0.63% +0.565 pp | 0.00% +0.000 pp | USD1.58 +5.7% | 20 qtrs — |
| 13 | MARSHALL WACE, LLP | 1.36M +1.4M (+100.0%) | 2.27M +2.3M (+100.0%) | 0.60% +0.595 pp | 0.00% +0.002 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 14 | STATE STREET CORP | 1.02M +60.6K (+6.3%) | 1.70M +82.1K (+5.1%) | 0.44% +0.026 pp | 0.00% +0.000 pp | USD1.52 +9.9% | 26 qtrs — |
| 15 | JANE STREET GROUP, LLC | 1.00M +859.9K (+593.6%) | 1.68M +1.4M (+585.4%) | 0.44% +0.376 pp | 0.00% +0.000 pp | USD1.56 +7.1% | 26 qtrs — |
| 16 | RED CRANE WEALTH MANAGEMENT, LLC | 597.3K +85.9K (+16.8%) | 997.4K +133.2K (+15.4%) | 0.26% +0.037 pp | 0.82% +0.087 pp | USD0.69 +142.0% | 5 qtrs — |
| 17 | CITADEL ADVISORS LLC | 507.1K +313.1K (+161.4%) | 846.8K +519.0K (+158.3%) | 0.22% +0.137 pp | 0.00% +0.000 pp | USD1.35 +23.7% | 5 qtrs — |
| 18 | NORTHERN TRUST CORP | 479.3K +35.9K (+8.1%) | 800.4K +51.1K (+6.8%) | 0.21% +0.015 pp | 0.00% +0.000 pp | USD1.37 +21.9% | 26 qtrs — |
| 19 | EAM INVESTORS, LLC | 442.2K +— (+0.0%) | 738.5K -8.8K (-1.2%) | 0.19% 0.000 pp | 0.08% -0.003 pp | USD1.69 -1.2% | 2 qtrs — |
| 20 | BARCLAYS PLC | 348.5K +137.2K (+64.9%) | 582.0K +390.7K (+204.3%) | 0.15% +0.060 pp | 0.00% +0.000 pp | USD1.62 +3.1% | 16 qtrs — |
| 21 | GSA CAPITAL PARTNERS LLP | 331.0K -339.9K (-50.7%) | 553.0K -581.0K (-51.2%) | 0.14% -0.149 pp | 0.05% -0.047 pp | USD0.51 +227.5% | 6 qtrs — |
| 22 | OMERS ADMINISTRATION CORP | 283.2K +283.2K (+100.0%) | 472.9K +472.9K (+100.0%) | 0.12% +0.124 pp | 0.00% +0.003 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 23 | SEI INVESTMENTS CO | 269.3K +269.3K (+100.0%) | 449.7K +449.7K (+100.0%) | 0.12% +0.118 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 24 | TWO SIGMA INVESTMENTS, LP | 265.6K -88.8K (-25.0%) | 443.5K -155.3K (-25.9%) | 0.12% -0.039 pp | 0.00% 0.000 pp | USD0.61 +173.8% | 5 qtrs — |
| 25 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 221.0K +— (+0.0%) | 369.1K -4.4K (-1.2%) | 0.10% 0.000 pp | 0.01% 0.000 pp | USD1.39 +20.1% | 26 qtrs — |
| 26 | QUBE RESEARCH & TECHNOLOGIES LTD | 211.3K +211.3K (+100.0%) | 353.0K +353.0K (+100.0%) | 0.09% +0.092 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 3 qtrs — |
| 27 | BANK OF AMERICA CORP /DE/ | 197.8K -35.6K (-15.2%) | 330.4K -64.1K (-16.2%) | 0.09% -0.016 pp | 0.00% +0.000 pp | USD1.24 +34.7% | 26 qtrs — |
| 28 | FMR LLC | 192.0K -2.1K (-1.1%) | 320.6K -7.3K (-2.2%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD0.52 +221.2% | 16 qtrs — |
| 29 | UBS GROUP AG | 183.1K -25.0K (-12.0%) | 305.8K -45.8K (-13.0%) | 0.08% -0.011 pp | 0.00% +0.000 pp | USD0.84 +98.8% | 26 qtrs — |
| 30 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 181.7K +181.7K (+100.0%) | 303.4K +303.4K (+100.0%) | 0.08% +0.079 pp | 0.00% +0.002 pp | USD1.67 +0.0% | 3 qtrs — |
| 31 | POINT72 ASSET MANAGEMENT, L.P. | 159.4K +159.4K (+100.0%) | 266.2K +266.2K (+100.0%) | 0.07% +0.070 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 32 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 129.9K -88.4K (-40.5%) | 216.9K -151.9K (-41.2%) | 0.06% -0.039 pp | 0.00% +0.000 pp | USD1.57 +6.4% | 26 qtrs — |
| 33 | COMMONWEALTH EQUITY SERVICES, LLC | 104.3K +3.3K (+3.3%) | 174.1K +3.1K (+1.8%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD1.44 +16.0% | 8 qtrs — |
| 34 | WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 101.3K +— (+0.0%) | 169.2K -2.0K (-1.2%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD2.45 -31.8% | 17 qtrs — |
| 35 | HIGHTOWER ADVISORS, LLC | 98.4K +— (+0.0%) | 164.3K -2.0K (-1.2%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD1.43 +16.8% | 21 qtrs — |
| 36 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 84.6K +84.6K (+100.0%) | 141.3K +141.3K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.004 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 37 | RAYMOND JAMES FINANCIAL INC | 80.2K -10.2K (-11.3%) | 133.9K -18.8K (-12.3%) | 0.04% -0.005 pp | 0.00% +0.000 pp | USD0.96 +74.0% | 5 qtrs — |
| 38 | HUDSON BAY CAPITAL MANAGEMENT LP | 74.4K +74.4K (+100.0%) | 124.3K +124.3K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 3 qtrs — |
| 39 | VOLEON CAPITAL MANAGEMENT LP | 71.0K +71.0K (+100.0%) | 118.5K +118.5K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.003 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 40 | CITIGROUP INC | 70.7K +69.3K (+4,931.2%) | 118.1K +115.8K (+4,871.9%) | 0.03% +0.030 pp | 0.00% +0.000 pp | USD1.65 +1.2% | 26 qtrs — |
| 41 | SQUAREPOINT OPS LLC | 65.1K +65.1K (+100.0%) | 108.7K +108.7K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 12 qtrs — |
| 42 | CATALYST FUNDS MANAGEMENT PTY LTD | 62.4K +— (+0.0%) | 104.2K -1.2K (-1.2%) | 0.03% 0.000 pp | 0.02% +0.008 pp | USD0.91 +83.5% | 3 qtrs — |
| 43 | NWAM LLC | 62.1K +27.1K (+77.5%) | 98.8K +41.4K (+72.1%) | 0.03% +0.012 pp | 0.01% +0.002 pp | USD1.49 +12.1% | 3 qtrs — |
| 44 | JEFFERIES FINANCIAL GROUP INC. | 59.1K -3.1K (-5.0%) | 98.7K -6.4K (-6.1%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD1.69 -1.2% | 2 qtrs — |
| 45 | FORT SHERIDAN ADVISORS LLC | 55.2K +— (+0.0%) | 92.1K -1.1K (-1.2%) | 0.02% 0.000 pp | 0.01% -0.001 pp | USD1.36 +22.8% | 20 qtrs — |
| 46 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 53.1K +24.0K (+82.5%) | 88.7K +39.5K (+80.3%) | 0.02% +0.011 pp | 0.00% +0.000 pp | USD1.68 -0.6% | 2 qtrs — |
| 47 | CIBC WORLD MARKET INC. | 47.1K +— (+0.0%) | 78.6K -941.0 (-1.2%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.17 +42.7% | 10 qtrs — |
| 48 | BEIRNE WEALTH CONSULTING SERVICES, LLC | 45.0K +— (+0.0%) | 75.2K -900.0 (-1.2%) | 0.02% +0.000 pp | 0.02% +0.004 pp | USD0.94 +77.7% | 26 qtrs — |
| 49 | XTX TOPCO LTD | 42.3K +42.3K (+100.0%) | 70.6K +70.6K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.002 pp | USD1.67 +0.0% | 4 qtrs — |
| 50 | JAIN GLOBAL LLC | 38.9K +26.0K (+202.3%) | 64.9K +43.2K (+198.7%) | 0.02% +0.011 pp | 0.00% +0.000 pp | USD1.42 +17.6% | 3 qtrs — |
| 51 | ADVISOR GROUP HOLDINGS, INC. | 38.7K -46.1K (-54.4%) | 64.6K -58.3K (-47.5%) | 0.02% -0.020 pp | 0.00% 0.000 pp | USD0.78 +114.1% | 24 qtrs — |
| 52 | RATHBONES GROUP PLC | 35.0K +— (+0.0%) | 58.5K -700.0 (-1.2%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.18 +41.5% | 10 qtrs — |
| 53 | ORG PARTNERS LLC | 34.6K -1.1K (-3.1%) | 57.8K -2.6K (-4.2%) | 0.02% -0.001 pp | 0.01% -0.001 pp | USD0.45 +271.1% | 4 qtrs — |
| 54 | TRUST CO OF TOLEDO NA /OH/ | 33.8K +— (+0.0%) | 56.4K -676.0 (-1.2%) | 0.01% +0.000 pp | 0.01% 0.000 pp | USD1.47 +13.6% | 12 qtrs — |
| 55 | QUADRATURE CAPITAL LTD | 30.6K -148.4K (-82.9%) | 51.2K -253.2K (-83.2%) | 0.01% -0.065 pp | 0.00% -0.003 pp | USD1.69 -1.2% | 2 qtrs — |
| 56 | EQUITABLE HOLDINGS, INC. | 30.0K +— (+0.0%) | 50.1K -601.0 (-1.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.69 -1.2% | 2 qtrs — |
| 57 | LPL FINANCIAL LLC | 27.8K +3.7K (+15.5%) | 46.4K +5.7K (+14.1%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD1.74 -4.0% | 26 qtrs — |
| 58 | KESTRA ADVISORY SERVICES, LLC | 27.7K +17.6K (+174.7%) | 46.3K +29.3K (+171.5%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD1.68 -0.6% | 2 qtrs — |
| 59 | SCOTIA CAPITAL INC. | 26.8K +— (+0.0%) | 44.7K -536.0 (-1.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.79 +111.4% | 26 qtrs — |
| 60 | VICTORY CAPITAL MANAGEMENT INC | 25.1K -1.1K (-4.3%) | 41.8K -2.4K (-5.4%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.04 +60.6% | 26 qtrs — |
| 61 | TWO SIGMA SECURITIES, LLC | 23.6K +23.6K (+100.0%) | 39.4K +39.4K (+100.0%) | 0.01% +0.010 pp | 0.01% +0.005 pp | USD1.67 +0.0% | 3 qtrs — |
| 62 | IEQ CAPITAL, LLC | 23.4K -137.0K (-85.4%) | 39.2K -231.9K (-85.6%) | 0.01% -0.060 pp | 0.00% -0.001 pp | USD1.58 +5.7% | 3 qtrs — |
| 63 | BANK OF NEW YORK MELLON CORP | 23.2K -7.9K (-25.4%) | 38.8K -13.9K (-26.3%) | 0.01% -0.004 pp | 0.00% +0.000 pp | USD1.55 +7.7% | 26 qtrs — |
| 64 | PFG INVESTMENTS, LLC | 22.2K +1.0K (+4.7%) | 37.1K +1.2K (+3.5%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD1.51 +10.6% | 12 qtrs — |
| 65 | SUMMITTX CAPITAL, L.P. | 21.3K -52.5K (-71.1%) | 35.6K -89.2K (-71.5%) | 0.01% -0.023 pp | 0.00% -0.004 pp | USD0.91 +83.5% | 3 qtrs — |
| 66 | ELCO MANAGEMENT CO., LLC | 20.5K +500.0 (+2.5%) | 34.2K +435.0 (+1.3%) | 0.01% +0.000 pp | 0.02% +0.004 pp | USD1.14 +46.5% | 14 qtrs — |
| 67 | PRIVATE ADVISOR GROUP, LLC | 20.1K +— (+0.0%) | 33.5K -402.0 (-1.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.45 +271.1% | 4 qtrs — |
| 68 | CHAPIN DAVIS, INC. | 20.0K +— (+0.0%) | 33.4K -401.0 (-1.2%) | 0.01% +0.000 pp | 0.01% -0.001 pp | USD0.45 +271.1% | 4 qtrs — |
| 69 | ALLEGHENY FINANCIAL GROUP LTD | 20.0K +— (+0.0%) | 33.4K -400.0 (-1.2%) | 0.01% +0.000 pp | 0.00% -0.001 pp | USD1.18 +41.5% | 21 qtrs — |
| 70 | DEFINE FINANCIAL, LLC | 20.0K +20.0K (+100.0%) | 33.4K +33.4K (+100.0%) | 0.01% +0.009 pp | 0.02% +0.019 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 71 | DLD ASSET MANAGEMENT, LP | 20.0K +20.0K (+100.0%) | 33.4K +33.4K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.003 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 72 | TOWER RESEARCH CAPITAL LLC (TRC) | 19.5K +15.9K (+448.2%) | 32.5K +26.5K (+441.7%) | 0.01% +0.007 pp | 0.00% +0.001 pp | USD1.50 +11.3% | 13 qtrs — |
| 73 | CATALYTIC WEALTH RIA, LLC | 18.7K +— (+0.0%) | 31.3K -374.0 (-1.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.69 -1.2% | 2 qtrs — |
| 74 | CREATIVE PLANNING | 18.2K +439.0 (+2.5%) | 30.4K +378.0 (+1.3%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.23 +35.8% | 26 qtrs — |
| 75 | WELLS FARGO & COMPANY/MN | 17.9K -10.2K (-36.3%) | 30.0K -17.6K (-37.0%) | 0.01% -0.005 pp | 0.00% +0.000 pp | USD1.01 +65.3% | 26 qtrs — |
| 76 | MAI CAPITAL MANAGEMENT | 16.6K -1.8K (-9.8%) | 27.8K -3.4K (-10.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.36 +22.8% | 15 qtrs — |
| 77 | ASSUREDPARTNERS INVESTMENT ADVISORS, LLC | 16.5K +— (+0.0%) | 27.6K -330.0 (-1.2%) | 0.01% +0.000 pp | 0.00% -0.002 pp | USD0.50 +234.0% | 5 qtrs — |
| 78 | BNP PARIBAS ARBITRAGE, SNC | 15.9K +15.8K (+9,863.8%) | 26.6K +26.4K (+9,760.4%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD1.66 +0.6% | 5 qtrs — |
| 79 | ELGETHUN CAPITAL MANAGEMENT | 15.0K +— (+0.0%) | 25.1K -675.0 (-2.6%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD0.89 +87.6% | 25 qtrs — |
| 80 | SKYOAK WEALTH, LLC | 15.0K +— (+0.0%) | 25.1K -300.0 (-1.2%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD0.89 +87.6% | 25 qtrs — |
| 81 | SG AMERICAS SECURITIES, LLC | 14.8K +14.8K (+100.0%) | 25.0K +25.0K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 6 qtrs — |
| 82 | SCHONFELD STRATEGIC ADVISORS LLC | 13.3K +13.3K (+100.0%) | 22.2K +22.2K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 3 qtrs — |
| 83 | MARINER, LLC | 13.1K +1.9K (+17.0%) | 21.9K +3.0K (+15.6%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD1.36 +22.8% | 14 qtrs — |
| 84 | LAFAYETTE INVESTMENTS, INC. | 13.0K +— (+0.0%) | 21.7K -260.0 (-1.2%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD1.90 -12.1% | 21 qtrs — |
| 85 | OXFORD FINANCIAL GROUP LTD | 12.6K +— (+0.0%) | 21.1K -253.0 (-1.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.76 -5.1% | 21 qtrs — |
| 86 | STONERIDGE INVESTMENT PARTNERS LLC | 12.5K +12.5K (+100.0%) | 21.0K +21.0K (+100.0%) | 0.01% +0.006 pp | 0.01% +0.015 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 87 | PISCATAQUA SAVINGS BANK | 12.5K +— (+0.0%) | 20.7K -375.0 (-1.8%) | 0.01% +0.000 pp | 0.01% -0.002 pp | USD2.35 -28.9% | 20 qtrs — |
| 88 | FOUNDERS CAPITAL MANAGEMENT | 12.0K +— (+0.0%) | 20.0K -240.0 (-1.2%) | 0.01% +0.000 pp | 0.01% 0.000 pp | USD0.45 +271.1% | 21 qtrs — |
| 89 | TWO SIGMA ADVISERS, LP | 11.8K +100.0 (+0.9%) | 19.7K -67.0 (-0.3%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.63 +165.1% | 26 qtrs — |
| 90 | FARROW FINANCIAL INC. | 11.5K +— (+0.0%) | 19.2K -230.0 (-1.2%) | 0.01% +0.000 pp | 0.01% 0.000 pp | USD1.09 +53.2% | 9 qtrs — |
| 91 | LAZARI CAPITAL MANAGEMENT, INC. | 10.5K -317.0 (-2.9%) | 17.5K -746.0 (-4.1%) | 0.00% 0.000 pp | 0.01% 0.000 pp | USD0.50 +234.0% | 5 qtrs — |
| 92 | THRIVENT FINANCIAL FOR LUTHERANS | 10.0K +10.0K (+100.0%) | 17.0K +17.0K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 5 qtrs — |
| 93 | WOODTRUST FINANCIAL CORP | 10.0K +10.0K (+100.0%) | 17.0K +17.0K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.002 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 94 | SPROTT INC. | 10.0K +— (+0.0%) | 16.7K -200.0 (-1.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.91 +83.5% | 3 qtrs — |
| 95 | BOOTHBAY FUND MANAGEMENT, LLC | 10.0K +10.0K (+100.0%) | 16.7K +16.7K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD1.67 +0.0% | 1 qtrs NEW |
| 96 | BEVERLY HILLS PRIVATE WEALTH, LLC | 10.0K +— (+0.0%) | 16.7K -200.0 (-1.2%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD1.69 -1.2% | 2 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 35 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.05% | 790.0K | 0.60% |
| 2 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.03% | 288.7K | 0.20% |
| 3 | iShares Biotechnology ETF IBB | 0.02% | 1.72M | 0.44% |
| 4 | iShares Russell 2000 Growth ETF IWO | 0.01% | 2.22M | 0.24% |
| 5 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 225.8K | 0.30% |
| 6 | Global X - Russell 2000 ETF RSSL | 0.01% | 110.3K | 0.08% |
| 7 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.01% | 23.8K | 0.25% |
| 8 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 3.7K | 0.39% |
| 9 | iShares Russell 2000 ETF IWM | 0.01% | 5.43M | 0.19% |
| 10 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.01% | 35.5K | 0.36% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.50
Neutral
Ratio by volume
3.00
Bullish
Buys
6
Sells
4
Shares acquired
5.25M
Shares disposed
52.7K
Cash buys
1.00
Cash sales
—
Net activity
+5,199,629
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | Culley Brian M | Director / Officer | P-Purchase | A | Common Shares | 15,000 | 1.63 | 24.4K | 255,516 | D | ↗ |
| 2026-03-05 | Samuel George A. III | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 900,000 | 1.84 | 1.66M | 900,000 | D | ↗ |
| 2026-03-05 | Howe Jill Ann | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,050,000 | 1.84 | 1.93M | 1,050,000 | D | ↗ |
| 2026-03-05 | Culley Brian M | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 3,250,000 | 1.84 | 5.98M | 3,250,000 | D | ↗ |
| 2026-02-11 | Samuel George A. III | Officer | M-Exempt | A | Common Shares | 6,075 | 0.00 | — | 33,565 | D | ↗ |
| 2026-02-11 | Culley Brian M | Director / Officer | M-Exempt | A | Common Shares | 31,250 | 0.00 | — | 253,385 | D | ↗ |
| 2025-12-19 | Samuel George A. III | Officer | F-InKind | D | Common Shares | 65 | 1.68 | 109.20 | 27,490 | D | ↗ |
| 2025-12-19 | Culley Brian M | Director / Officer | F-InKind | D | Common Shares | 334 | 1.68 | 561.12 | 222,135 | D | ↗ |
| 2025-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.90 | 67.3K | 75,000 | D | ↗ |
| 2025-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.90 | 67.3K | 75,000 | D | ↗ |
| 2025-07-01 | Jayasuriya Anula | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.90 | 67.3K | 75,000 | D | ↗ |
| 2025-07-01 | Bradsher Neal C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 75,000 | 0.90 | 67.3K | 75,000 | D | ↗ |
| 2025-07-01 | Amin Dipti | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.90 | 67.3K | 75,000 | D | ↗ |
| 2025-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.90 | 67.3K | 75,000 | D | ↗ |
| 2025-03-10 | Samuel George A. III | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 750,000 | 0.53 | 397.5K | 750,000 | D | ↗ |
| 2025-03-10 | Howe Jill Ann | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 750,000 | 0.53 | 397.5K | 750,000 | D | ↗ |
| 2025-03-10 | Culley Brian M | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 2,300,000 | 0.53 | 1.22M | 2,300,000 | D | ↗ |
| 2025-02-11 | Samuel George A. III | Officer | M-Exempt | D | Restricted Stock Units | 6,076 | 0.00 | — | 6,075 | D | ↗ |
| 2025-02-11 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 31,249 | 0.00 | — | 31,250 | D | ↗ |
| 2025-01-27 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 7,894,737 | 0.76 | 6.00M | 49,560,992 | D | ↗ |
| 2024-11-26 | Samuel George A. III | Officer | P-Purchase | A | Common Shares | 15,000 | 0.60 | 9.0K | 22,184 | D | ↗ |
| 2024-11-26 | Howe Jill Ann | Officer | P-Purchase | A | Common Shares | 15,000 | 0.59 | 8.9K | 25,500 | D | ↗ |
| 2024-11-22 | Mulroy Michael H. | Director | P-Purchase | A | Common Shares | 40,000 | 0.57 | 22.6K | 298,555 | D | ↗ |
| 2024-11-21 | Culley Brian M | Director / Officer | P-Purchase | A | Common Shares | 40,000 | 0.60 | 24.0K | 194,842 | D | ↗ |
| 2024-08-16 | Howe Jill Ann | Officer | P-Purchase | A | Common Shares | 10,500 | 0.89 | 9.3K | 10,500 | — | ↗ |
| 2024-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-07-01 | Jayasuriya Anula | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-07-01 | BRADSHER NEAL C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-07-01 | BAILEY DON M | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-07-01 | Amin Dipti | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.95 | 71.6K | 75,000 | — | ↗ |
| 2024-05-24 | Culley Brian M | Director / Officer | P-Purchase | A | Common Shares | 10,000 | 1.05 | 10.5K | 154,842 | — | ↗ |
| 2024-03-07 | Samuel George A. III | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 650,000 | 1.13 | 734.5K | 650,000 | — | ↗ |
| 2024-03-07 | Howe Jill Ann | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 650,000 | 1.13 | 734.5K | 650,000 | — | ↗ |
| 2024-03-07 | Culley Brian M | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,900,000 | 1.13 | 2.15M | 1,900,000 | — | ↗ |
| 2024-02-11 | Samuel George A. III | Officer | M-Exempt | D | Restricted Stock Units | 6,076 | 0.00 | — | 12,151 | — | ↗ |
| 2024-02-11 | Culley Brian M | Director / Officer | M-Exempt | A | Common Shares, no par value | 31,249 | 0.00 | — | 157,648 | — | ↗ |
| 2024-02-08 | BAILEY DON M | Director | P-Purchase | A | Common Shares, no par value | 96,155 | 1.04 | 100.0K | 158,801 | — | ↗ |
| 2024-02-06 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 6,730,770 | 1.04 | 7.00M | 41,666,255 | — | ↗ |
| 2023-12-29 | Jayasuriya Anula | Director | P-Purchase | A | Common Shares, no par value | 10,000 | 1.09 | 10.9K | 10,000 | — | ↗ |
| 2023-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | KINGSLEY ALFRED D | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | Jayasuriya Anula | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | BRADSHER NEAL C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | BAILEY DON M | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | Amin Dipti | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.41 | 70.5K | 50,000 | — | ↗ |
| 2023-03-09 | Samuel George A. III | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 650,000 | 1.46 | 949.0K | 650,000 | — | ↗ |
| 2023-03-09 | Howe Jill Ann | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 1.46 | 219.0K | 150,000 | — | ↗ |
| 2023-03-09 | Hogge Gary S. | Officer | A-Award | A | Employee Stock Option (right to buy) | 400,000 | 1.46 | 584.0K | 400,000 | — | ↗ |
| 2023-03-09 | Culley Brian M | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,900,000 | 1.46 | 2.77M | 1,900,000 | — | ↗ |
| 2023-02-11 | Samuel George A. III | Officer | F-InKind | D | Common Shares, no par value | 2,478 | 1.35 | 3.3K | 3,598 | — | ↗ |
| 2023-02-11 | Hogge Gary S. | Officer | M-Exempt | D | Restricted Stock Units | 13,020 | 0.00 | — | 39,061 | — | ↗ |
| 2023-02-11 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 31,249 | 0.00 | — | 93,748 | — | ↗ |
| 2022-12-31 | KINGSLEY ALFRED D | Director | — | I | Common Shares, no par value | 0 | 0.00 | — | 375,351 | — | ↗ |
| 2022-11-14 | Howe Jill Ann | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-07-07 | Hernandez Alexandra | Director / Officer | — | D | Employee Stock Option (Right to Buy) | 100,000 | 0.90 | 90.0K | 0 | — | ↗ |
| 2022-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 1.57 | 78.5K | 50,000 | — | ↗ |
| 2022-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 1.57 | 78.5K | 50,000 | — | ↗ |
| 2022-07-01 | KINGSLEY ALFRED D | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-07-01 | Jayasuriya Anula | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-07-01 | BRADSHER NEAL C | Director | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-07-01 | BAILEY DON M | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 1.57 | 78.5K | 50,000 | — | ↗ |
| 2022-07-01 | Amin Dipti | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-06-30 | Culley Brian M | Officer | M-Exempt | D | Restricted Stock Units | 15,450 | 0.00 | — | 0 | — | ↗ |
| 2022-03-31 | Culley Brian M | Officer | P-Purchase | A | Common Shares, no par value | 6,400 | 1.53 | 9.8K | 97,787 | — | ↗ |
| 2022-03-28 | Amin Dipti | Director | P-Purchase | A | Common Shares, no par value | 35,000 | 1.63 | 57.1K | 35,000 | — | ↗ |
| 2022-03-25 | Culley Brian M | Officer | P-Purchase | A | Common Shares, no par value | 5,250 | 1.38 | 7.2K | 81,280 | — | ↗ |
| 2022-03-25 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 0 | 0.00 | — | 34,935,485 | — | ↗ |
| 2022-03-24 | Mulroy Michael H. | Director | P-Purchase | A | Common Shares, no par value | 7,000 | 1.40 | 9.8K | 258,555 | — | ↗ |
| 2022-03-24 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 200,000 | 1.42 | 284.3K | 34,465,485 | — | ↗ |
| 2022-03-23 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 0 | 0.00 | — | 34,265,485 | — | ↗ |
| 2022-03-23 | BRADSHER NEAL C | Director | P-Purchase | A | Common Shares | 0 | 0.00 | — | 34,265,485 | — | ↗ |
| 2022-03-10 | Samuel George A. III | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 650,000 | 0.00 | — | 650,000 | — | ↗ |
| 2022-03-10 | Hogge Gary S. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 450,000 | 0.00 | — | 450,000 | — | ↗ |
| 2022-03-10 | Culley Brian M | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,250,000 | 0.00 | — | 1,250,000 | — | ↗ |
| 2022-03-10 | Cook Kevin Leon | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 650,000 | 0.00 | — | 650,000 | — | ↗ |
| 2022-02-11 | Samuel George A. III | Officer | A-Award | A | Restricted Stock Units | 24,303 | 0.00 | — | 24,303 | — | ↗ |
| 2022-02-11 | Hogge Gary S. | Officer | A-Award | A | Restricted Stock Units | 52,081 | 0.00 | — | 52,081 | — | ↗ |
| 2022-02-11 | Culley Brian M | Director / Officer | A-Award | A | Restricted Stock Units | 124,997 | 0.00 | — | 124,997 | — | ↗ |
| 2022-02-11 | Cook Kevin Leon | Officer | A-Award | A | Restricted Stock Units | 13,888 | 0.00 | — | 13,888 | — | ↗ |
| 2021-12-31 | KINGSLEY ALFRED D | Director | — | I | Common Shares, no par value | 0 | 0.00 | — | 375,351 | — | ↗ |
| 2021-12-31 | Culley Brian M | Director / Officer | F-InKind | D | Common Shares, no par value | 5,343 | 2.45 | 13.1K | 76,030 | — | ↗ |
| 2021-12-29 | Hogge Gary S. | Officer | S-Sale | D | Common Shares, no par value | 28,445 | 2.44 | 69.4K | 0 | — | ↗ |
| 2021-12-28 | Hogge Gary S. | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 79,689 | 1.14 | 90.8K | 32,811 | — | ↗ |
| 2021-09-30 | Culley Brian M | Director / Officer | M-Exempt | A | Common Shares, no par value | 15,450 | 0.00 | — | 71,266 | — | ↗ |
| 2021-09-01 | Samuel George A. III | Officer | A-Award | A | Employee Stock Option (right to buy) | 695,000 | 2.55 | 1.77M | 695,000 | — | ↗ |
| 2021-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-07-01 | KINGSLEY ALFRED D | Director | A-Award | A | Stock Option (right to buy) | 80,000 | 2.86 | 228.8K | 80,000 | — | ↗ |
| 2021-07-01 | Jayasuriya Anula | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-07-01 | BRADSHER NEAL C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-07-01 | BAILEY DON M | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-07-01 | Amin Dipti | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 2.86 | 143.0K | 50,000 | — | ↗ |
| 2021-06-30 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 15,450 | 0.00 | — | 61,800 | — | ↗ |
| 2021-06-29 | Russell Angus C. | Director | M-Exempt | A | Common Shares, no par value | 24,720 | 2.20 | 54.4K | 92,220 | — | ↗ |
| 2021-06-29 | ANDREWS DEBORAH J | Director | M-Exempt | A | Common Shares, no par value | 24,720 | 2.20 | 54.4K | 34,720 | — | ↗ |
| 2021-06-28 | Culley Brian M | Director / Officer | S-Sale | D | Common Shares, no par value | 450,000 | 2.87 | 1.29M | 45,709 | — | ↗ |
| 2021-06-25 | BRADSHER NEAL C | Director / 10% Owner | M-Exempt | A | Common Shares | 24,720 | 2.20 | 54.4K | 87,628 | — | ↗ |
| 2021-06-22 | KINGSLEY ALFRED D | Director | M-Exempt | A | Common Shares, no par value | 61,800 | 2.20 | 136.0K | 5,470,245 | — | ↗ |
| 2021-06-21 | Cook Kevin Leon | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-18 | Mulroy Michael H. | Director | M-Exempt | A | Common Shares, no par value | 24,720 | 2.20 | 54.4K | 251,555 | — | ↗ |
| 2021-05-04 | Jayasuriya Anula | Director | A-Award | A | Stock Option (Right to Buy) | 90,000 | 2.58 | 232.2K | 90,000 | — | ↗ |
| 2021-04-20 | Amin Dipti | Director | A-Award | A | Stock Option (Right to Buy) | 90,000 | 2.28 | 205.2K | 90,000 | — | ↗ |
| 2021-03-31 | Culley Brian M | Director / Officer | M-Exempt | A | Common Shares, no par value | 15,450 | 2.35 | 36.3K | 201,052 | — | ↗ |
| 2021-03-30 | Hernandez Alexandra | Director / Officer | M-Exempt | A | Common Shares, no par value | 6,000 | 0.69 | 4.2K | 6,000 | — | ↗ |
| 2021-03-15 | Leavitt Chase C. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 699,100 | 2.43 | 1.70M | 699,100 | — | ↗ |
| 2021-03-15 | Hogge Gary S. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 419,500 | 2.43 | 1.02M | 419,500 | — | ↗ |
| 2021-03-15 | Hernandez Alexandra | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 42,700 | 2.43 | 103.8K | 42,700 | — | ↗ |
| 2021-03-15 | Culley Brian M | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,165,100 | 2.43 | 2.83M | 1,165,100 | — | ↗ |
| 2021-01-20 | Hernandez Alexandra | Director / Officer | — | D | Employee Stock Option (Right to Buy) | 100,000 | 0.90 | 90.0K | 0 | — | ↗ |
| 2020-12-31 | KINGSLEY ALFRED D | Director | — | I | Common Shares, no par value | 0 | 0.00 | — | 1,043,346 | — | ↗ |
| 2020-12-31 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 15,450 | 0.00 | — | 92,700 | — | ↗ |
| 2020-09-30 | Culley Brian M | Director / Officer | M-Exempt | A | Common Shares, no par value | 15,450 | 0.94 | 14.5K | 180,838 | — | ↗ |
| 2020-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.83 | 33.1K | 40,000 | — | ↗ |
| 2020-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.83 | 33.1K | 40,000 | — | ↗ |
| 2020-07-01 | KINGSLEY ALFRED D | Director | A-Award | A | Stock Option (Right to Buy) | 70,000 | 0.83 | 57.8K | 70,000 | — | ↗ |
| 2020-07-01 | FARRELL STEPHEN C | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.83 | 33.1K | 40,000 | — | ↗ |
| 2020-07-01 | BRADSHER NEAL C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 40,000 | 0.83 | 33.1K | 40,000 | — | ↗ |
| 2020-07-01 | BAILEY DON M | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.83 | 33.1K | 40,000 | — | ↗ |
| 2020-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.83 | 33.1K | 40,000 | — | ↗ |
| 2020-06-30 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 15,450 | 0.00 | — | 123,600 | — | ↗ |
| 2020-03-31 | Culley Brian M | Director / Officer | M-Exempt | A | Common Shares, no par value | 15,450 | 0.83 | 12.8K | 160,624 | — | ↗ |
| 2020-03-17 | Roberts Brandi | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 616,700 | 0.69 | 426.7K | 616,700 | — | ↗ |
| 2020-03-17 | Leavitt Chase C. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 616,700 | 0.69 | 426.7K | 616,700 | — | ↗ |
| 2020-03-17 | Hogge Gary S. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 444,000 | 0.69 | 307.2K | 444,000 | — | ↗ |
| 2020-03-17 | Culley Brian M | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,233,300 | 0.69 | 853.3K | 1,233,300 | — | ↗ |
| 2019-12-31 | KINGSLEY ALFRED D | Director | — | I | Common Shares, no par value | 0 | 0.00 | — | 375,351 | — | ↗ |
| 2019-12-31 | Culley Brian M | Director / Officer | F-InKind | D | Common Shares, no par value | 5,343 | 0.89 | 4.8K | 145,174 | — | ↗ |
| 2019-09-30 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 15,450 | 0.00 | — | 169,950 | — | ↗ |
| 2019-09-17 | Culley Brian M | Director / Officer | F-InKind | D | Common Shares, no par value | 21,371 | 1.00 | 21.4K | 124,960 | — | ↗ |
| 2019-08-15 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 0 | 0.00 | — | 34,005,379 | — | ↗ |
| 2019-08-14 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 0 | 0.00 | — | 33,992,233 | — | ↗ |
| 2019-08-13 | Roberts Brandi | Officer | P-Purchase | A | Common Shares | 5,000 | 1.01 | 5.1K | 5,000 | — | ↗ |
| 2019-08-13 | Leavitt Chase C. | Officer | P-Purchase | A | Common Shares | 5,000 | 1.02 | 5.1K | 5,000 | — | ↗ |
| 2019-08-13 | Culley Brian M | Director / Officer | P-Purchase | A | Common Shares | 10,000 | 1.01 | 10.1K | 84,531 | — | ↗ |
| 2019-08-13 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Shares | 10,000 | 0.99 | 9.9K | 33,990,826 | — | ↗ |
| 2019-07-31 | Leavitt Chase C. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 125,000 | 1.10 | 137.5K | 125,000 | — | ↗ |
| 2019-07-01 | Russell Angus C. | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 1.03 | 41.2K | 40,000 | — | ↗ |
| 2019-07-01 | Mulroy Michael H. | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 1.03 | 41.2K | 40,000 | — | ↗ |
| 2019-07-01 | KINGSLEY ALFRED D | Director | A-Award | A | Stock Option (Right to Buy) | 70,000 | 1.03 | 72.1K | 70,000 | — | ↗ |
| 2019-07-01 | FARRELL STEPHEN C | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 1.03 | 41.2K | 40,000 | — | ↗ |
| 2019-07-01 | BRADSHER NEAL C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 40,000 | 1.03 | 41.2K | 40,000 | — | ↗ |
| 2019-07-01 | BAILEY DON M | Director | A-Award | D | Stock Option (Right to Buy) | 40,000 | 1.03 | 41.2K | 40,000 | — | ↗ |
| 2019-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 1.03 | 41.2K | 40,000 | — | ↗ |
| 2019-06-30 | Roberts Brandi | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 1.10 | 165.0K | 150,000 | — | ↗ |
| 2019-05-20 | Leavitt Chase C. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 300,000 | 1.13 | 339.0K | 300,000 | — | ↗ |
| 2019-04-16 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | J-Other | A | Common Shares | 0 | 0.00 | — | 33,980,826 | — | ↗ |
| 2019-03-19 | Wirth Edward | Officer | A-Award | A | Option to Purchase Common Shares | 350,000 | 1.57 | 549.5K | 350,000 | — | ↗ |
| 2019-03-19 | Hogge Gary S. | Officer | — | D | Option to Purchase Common Shares | 247,200 | 2.11 | 521.6K | 0 | — | ↗ |
| 2019-03-19 | BAILEY DON M | Director | A-Award | D | Stock Option (Right to Buy) | 60,000 | 1.57 | 94.2K | 60,000 | — | ↗ |
| 2019-03-08 | Mulroy Michael H. | Director | A-Award | A | Common Shares, no par value | 194,271 | 0.00 | — | 226,821 | — | ↗ |
| 2019-03-08 | KINGSLEY ALFRED D | Director | A-Award | A | Common Shares, no par value | 6,390 | 0.00 | — | 5,457,945 | — | ↗ |
| 2019-03-08 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | J-Other | A | Common Shares | 3,757,430 | 0.00 | 3.8K | 33,728,991 | — | ↗ |
| 2019-03-08 | BAILEY DON M | Director | — | D | Common Shares, no par value | 0 | 0.00 | — | 62,647 | — | ↗ |
| 2019-01-07 | Roberts Brandi | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-01-01 | Culley Brian M | Director / Officer | M-Exempt | D | Restricted Stock Units | 100,000 | 0.00 | — | 0 | — | ↗ |
| 2018-12-31 | KINGSLEY ALFRED D | Director | — | I | Common Shares, no par value | 0 | 0.00 | — | 1,043,346 | — | ↗ |
| 2018-12-18 | SKIBSTED RUSSELL | Officer | M-Exempt | A | Common Shares, no par value | 22,500 | 0.00 | — | 31,859 | — | ↗ |
| 2018-12-18 | Patton Stephana Eilene | Officer | M-Exempt | A | Common Shares, no par value | 27,500 | 0.00 | — | 43,995 | — | ↗ |
| 2018-10-04 | SKIBSTED RUSSELL | Officer | F-InKind | D | Common Shares, no par value | 3,891 | 2.22 | 8.6K | 9,359 | — | ↗ |
| 2018-10-04 | Patton Stephana Eilene | Officer | F-InKind | D | Common Shares, no par value | 4,755 | 2.22 | 10.6K | 16,495 | — | ↗ |
| 2018-09-17 | WEST MICHAEL D | Director / Officer | M-Exempt | A | Common Shares, no par value | 10,938 | 0.00 | — | 897,696 | — | ↗ |
| 2018-09-17 | Culley Brian M | Director / Officer | A-Award | A | Non-Qualified Option to Purchase Common Shares | 1,500,000 | 2.31 | 3.47M | 1,500,000 | — | ↗ |
| 2018-09-11 | ANDREWS DEBORAH J | Director | P-Purchase | A | Common Shares, no par value | 1,604 | 2.35 | 3.8K | 10,000 | — | ↗ |
| 2018-07-10 | WEST MICHAEL D | Director / Officer | M-Exempt | D | Restricted Stock Units | 1,562 | 0.00 | — | 10,938 | — | ↗ |
| 2018-07-10 | MOHANTY ADITYA P. | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,687 | 0.00 | — | 32,813 | — | ↗ |
| 2018-07-01 | Russell Angus C. | Director | A-Award | A | Option to Purchase Common Shares | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2018-07-01 | Redmond Cavan M. | Director | A-Award | A | Option to Purchase Common Shares | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2018-07-01 | Mulroy Michael H. | Director | A-Award | A | Option to Purchase Common Shares | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2018-07-01 | KINGSLEY ALFRED D | Director / Officer | A-Award | A | Option to Purchase Common Shares | 70,000 | 2.06 | 144.2K | 70,000 | — | ↗ |
| 2018-07-01 | FARRELL STEPHEN C | Director | A-Award | A | Option to Purchase Common Shares | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2018-07-01 | BRADSHER NEAL C | Director / 10% Owner | A-Award | A | OPTION TO PURCHASE COMMON SHARES | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2018-07-01 | ANDREWS DEBORAH J | Director | A-Award | A | Option to Purchase Common Shares | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2018-04-10 | WEST MICHAEL D | Director / Officer | M-Exempt | D | Restricted Stock Units | 1,563 | 0.00 | — | 12,500 | — | ↗ |
| 2018-04-10 | MOHANTY ADITYA P. | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,688 | 0.00 | — | 37,500 | — | ↗ |
| 2018-03-15 | SKIBSTED RUSSELL | Officer | A-Award | A | Option to Purchase Common Shares | 150,000 | 2.54 | 381.0K | 150,000 | — | ↗ |
| 2018-03-15 | Patton Stephana Eilene | Officer | A-Award | A | Option to Purchase Common Shares | 125,000 | 2.54 | 317.5K | 125,000 | — | ↗ |
| 2018-03-15 | MOHANTY ADITYA P. | Director / Officer | A-Award | A | Option to Purchase Common Shares | 200,000 | 2.54 | 508.0K | 200,000 | — | ↗ |
| 2018-02-21 | Redmond Cavan M. | Director | — | D | Option to Purchase Common Shares | 60,000 | 2.64 | 158.4K | 0 | — | ↗ |
| 2018-01-10 | WEST MICHAEL D | Director / Officer | M-Exempt | A | Common Shares, no par value | 1,562 | 0.00 | — | 885,401 | — | ↗ |
| 2018-01-10 | MOHANTY ADITYA P. | Director / Officer | F-InKind | D | Common Shares, no par value | 2,057 | 2.68 | 5.5K | 95,252 | — | ↗ |
| 2017-12-31 | KINGSLEY ALFRED D | Director / Officer | — | I | Common Shares, no par value | 0 | 0.00 | — | 375,351 | — | ↗ |
| 2017-12-31 | GREENBELT CORP /NY | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-10-13 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 2,692,307 | 2.60 | 7.00M | 29,971,561 | — | ↗ |
| 2017-10-10 | WEST MICHAEL D | Director / Officer | M-Exempt | A | Common Shares, no par value | 1,563 | 0.00 | — | 884,427 | — | ↗ |
| 2017-10-10 | MOHANTY ADITYA P. | Director / Officer | M-Exempt | A | Common Shares, no par value | 4,688 | 0.00 | — | 94,384 | — | ↗ |
| 2017-08-23 | SKIBSTED RUSSELL | Officer | P-Purchase | A | Common Shares, no par value | 2,000 | 2.64 | 5.3K | 2,000 | — | ↗ |
| 2017-08-22 | WEST MICHAEL D | Director / Officer | P-Purchase | A | Common Shares, no par value | 2,000 | 2.60 | 5.2K | 882,864 | — | ↗ |
| 2017-08-22 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 2.60 | 26.0K | 27,279,254 | — | ↗ |
| 2017-08-21 | Patton Stephana Eilene | Officer | P-Purchase | A | Common Shares, no par value | 7,500 | 2.58 | 19.4K | 7,500 | — | ↗ |
| 2017-08-21 | MOHANTY ADITYA P. | Director / Officer | P-Purchase | A | Common Shares, no par value | 7,500 | 2.50 | 18.8K | 89,696 | — | ↗ |
| 2017-08-21 | ANDREWS DEBORAH J | Director | P-Purchase | A | Common Shares, no par value | 2,396 | 2.50 | 6.0K | 8,396 | — | ↗ |
| 2017-08-17 | KINGSLEY ALFRED D | Director / Officer | D-Return | D | Common Shares, no par value | 300,000 | 2.81 | 843.0K | 5,481,555 | — | ↗ |
| 2017-07-31 | KINGSLEY ALFRED D | Director / Officer | S-Sale | D | Common Shares, no par value | 150,000 | 2.80 | 420.0K | 5,781,555 | — | ↗ |
| 2017-07-31 | BROADWOOD PARTNERS, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 0 | 0.00 | — | 27,269,254 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-290.4K
Shares Outstanding
249.09M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Brian M. Culley Chief Executive Officer | 691.8K | — | — | 883.0K | 518.9K | 17.5K | 2.11M | 41.82% | ↗ |
| 2 | 2025 | Jill A. Howe Chief Financial Officer | 467.0K | — | — | 287.9K | 233.5K | 17.5K | 1.01M | 28.62% | ↗ |
| 3 | 2025 | George A. Samuel III General Counsel and Corporate Secretary | 448.5K | — | — | 287.9K | 224.3K | 17.5K | 978.2K | 29.43% | ↗ |
| 4 | 2024 | Brian M. Culley Chief Executive Officer | 665.1K | — | — | 1.50M | 349.2K | 17.3K | 2.53M | 59.30% | ↗ |
| 5 | 2024 | Jill A. Howe Chief Financial Officer | 431.6K | — | — | 514.2K | 151.1K | 17.3K | 1.11M | 46.15% | ↗ |
| 6 | 2024 | George A. Samuel III General Counsel and Corporate Secretary | 431.2K | — | — | 514.2K | 151.0K | 17.3K | 1.11M | 46.17% | ↗ |
| 7 | 2023 | Brian M. Culley Chief Executive Officer | 639.5K | — | — | 1.92M | 330.7K | 16.5K | 2.91M | 66.04% | ↗ |
| 8 | 2023 | George A. Samuel III General Counsel and Corporate Secretary | 381.9K | — | — | 656.3K | 156.1K | 16.5K | 1.21M | 54.20% | ↗ |
| 9 | 2023 | Gary S. Hogge, D.V.M., M.S. Ph.D. Former SVP Clinical and Medical Affairs | 353.1K | — | — | 403.9K | — | 103.6K | 860.6K | 46.93% | ↗ |
| 10 | 2023 | Jill A. Howe Chief Financial Officer | 415.0K | — | — | 151.5K | 155.9K | 16.5K | 738.9K | 20.50% | ↗ |
| 11 | 2022 | Brian M. Culley Chief Executive Officer | 609.0K | — | 268.5K | 1.16M | 319.9K | 15.3K | 2.37M | 60.20% | ↗ |
| 12 | 2022 | Kevin L. Cook Former Chief Financial Officer | 222.3K | — | 22.3K | 603.1K | — | 372.7K | 1.22M | 51.25% | ↗ |
| 13 | 2022 | George A. Samuel III General Counsel and Corporate Secretary | 394.8K | — | 39.1K | 603.1K | 150.9K | 15.3K | 1.20M | 53.38% | ↗ |
| 14 | 2022 | Jill A. Howe Chief Financial Officer | 55.0K | 50.0K | — | 934.9K | 20.5K | — | 1.06M | 88.16% | ↗ |
| 15 | 2021 | Brian M. Culley Chief Executive Officer | 580.0K | — | — | 1.84M | 319.0K | 14.5K | 2.75M | 66.84% | ↗ |
| 16 | 2021 | Kevin L. Cook Former Chief Financial Officer | 214.8K | 15.0K | — | 1.32M | 86.2K | 27.7K | 1.66M | 79.30% | ↗ |
| 17 | 2021 | Kevin L. Cook Chief Financial Officer | 214.8K | 101.2K | — | 1.32M | — | 27.7K | 1.66M | 79.30% | ↗ |
| 18 | 2021 | George A. Samuel III General Counsel and Corporate Secretary | 125.3K | — | — | 1.15M | 50.3K | — | 1.33M | 86.80% | ↗ |
| 19 | 2020 | Brian M. Culley Chief Executive Officer and Former Interim Chief Financial Officer | 551.9K | 262.2K | — | 521.6K | — | 14.3K | 1.35M | 38.64% | ↗ |
| 20 | 2020 | Brian M. Culley Chief Executive Officer | 551.9K | 262.2K | — | 521.6K | — | 14.3K | 1.35M | 38.64% | ↗ |
| 21 | 2020 | Chase C. Leavitt Former General Counsel and Corporate Secretary | 346.3K | 131.6K | — | 260.8K | — | 14.3K | 753.0K | 34.64% | ↗ |
| 22 | 2020 | Brandi L. Roberts Former Chief Financial Officer | 393.2K | — | — | 260.8K | — | 14.3K | 668.3K | 39.03% | ↗ |
| 23 | 2019 | Brandi L. Roberts Chief Financial Officer | 376.1K | 169.9K | — | 397.9K | — | 4.0K | 948.0K | 41.98% | ↗ |
| 24 | 2019 | Brandi L. Roberts Former Chief Financial Officer | 376.1K | 169.9K | — | 397.9K | — | 4.0K | 948.0K | 41.98% | ↗ |
| 25 | 2019 | Brian M. Culley Chief Executive Officer | 535.8K | 214.3K | — | — | — | 22.6K | 772.7K | 0.00% | ↗ |
| 26 | 2019 | Brian M. Culley Chief Executive Officer and Former Interim Chief Financial Officer | 535.8K | 214.3K | — | — | — | 22.6K | 772.7K | 0.00% | ↗ |
| 27 | 2019 | Edward D. Wirth, III, M.D., Ph.D. Former Chief Medical Officer | 285.0K | — | — | 379.8K | — | 30.0K | 694.8K | 54.66% | ↗ |
| 28 | 2019 | Chase C. Leavitt Former General Counsel and Corporate Secretary | 210.1K | 102.1K | — | 277.3K | — | 9.5K | 599.1K | 46.29% | ↗ |
| 29 | 2019 | Chase C. Leavitt General Counsel and Corporate Secretary | 210.1K | 102.1K | — | 277.3K | — | 9.5K | 599.1K | 46.29% | ↗ |
| 30 | 2018 | Brian M. Culley Chief Executive Officer | 154.9K | 70.0K | 693.0K | 1.92M | — | 27.5K | 2.86M | 91.18% | ↗ |
| 31 | 2018 | Michael D. West Former Co-Chief Executive Officer | 489.3K | 48.8K | 36.8K | — | — | 790.3K | 1.37M | 2.69% | ↗ |
| 32 | 2018 | Aditya P. Mohanty Former Co-Chief Executive Officer | 378.9K | 200.0K | 230.8K | 278.1K | — | 235.3K | 1.32M | 38.46% | ↗ |
| 33 | 2018 | Russell L. Skibsted Former Chief Financial Officer | 381.5K | 100.0K | 48.2K | 208.9K | — | 13.8K | 752.2K | 34.17% | ↗ |
| 34 | 2018 | Stephana E. Patton Former General Counsel | 324.1K | 97.0K | 58.9K | 174.4K | — | 13.8K | 668.0K | 34.91% | ↗ |
| 35 | 2017 | Aditya P. Mohanty Co-Chief Executive Officer | 511.4K | 206.0K | — | 1.14M | — | 13.5K | 1.87M | 60.84% | ↗ |
| 36 | 2017 | Aditya P. Mohanty Former Co-Chief Executive Officer | 511.4K | 206.0K | — | 1.14M | — | 13.5K | 1.87M | 60.84% | ↗ |
| 37 | 2017 | Michael D. West Former Co-Chief Executive Officer | 680.3K | 65.0K | — | 865.7K | — | 13.5K | 1.62M | 53.29% | ↗ |
| 38 | 2017 | Michael D. West Co-Chief Executive Officer | 680.3K | 65.0K | — | 865.7K | — | 13.5K | 1.62M | 53.29% | ↗ |
| 39 | 2017 | Russell L. Skibsted Chief Financial Officer | 368.2K | 108.0K | — | 433.0K | — | 13.5K | 922.8K | 46.93% | ↗ |
| 40 | 2017 | Russell L. Skibsted Former Chief Financial Officer | 368.2K | 108.0K | — | 433.0K | — | 13.5K | 922.8K | 46.93% | ↗ |
| 41 | 2017 | Stephana E. Patton General Counsel, Corporate Secretary and Chief Compliance Officer | 284.7K | 80.0K | — | 432.5K | — | 13.5K | 810.7K | 53.35% | ↗ |
| 42 | 2017 | Stephana E. Patton Former General Counsel | 284.7K | 80.0K | — | 432.5K | — | 13.5K | 810.7K | 53.35% | ↗ |
| 43 | 2017 | William Annett President and Chief Executive Officer of OncoCyte Corporation | 51.2K | — | — | 601.7K | — | 2.0K | 608.9K | 98.82% | ↗ |
| 44 | 2016 | Aditya P. Mohanty Co-Chief Executive Officer | 500.0K | 250.0K | 222.0K | 688.5K | — | 13.3K | 1.67M | 54.40% | ↗ |
| 45 | 2016 | Michael D. West Co-Chief Executive Officer | 680.3K | 65.0K | 74.0K | 321.3K | — | 13.3K | 1.15M | 34.26% | ↗ |
| 46 | 2016 | William Annett President and Chief Executive Officer of OncoCyte Corporation | 380.0K | 171.0K | — | 481.5K | — | 12.1K | 1.04M | 46.09% | ↗ |
| 47 | 2016 | Russell L. Skibsted Chief Financial Officer | 360.0K | 120.0K | — | 98.1K | — | 13.3K | 591.4K | 16.59% | ↗ |
| 48 | 2015 | Robert W. Peabody Former Senior Vice-President, and Chief Financial Officer | 707.7K | 45.0K | — | 724.3K | — | 18.0K | 1.49M | 48.46% | ↗ |
| 49 | 2015 | Michael D. West Co-Chief Executive Officer | 680.3K | 65.0K | — | 654.8K | — | 38.3K | 1.44M | 45.52% | ↗ |
| 50 | 2015 | William Annett President and Chief Executive Officer of OncoCyte Corporation | 173.3K | 93.3K | — | 957.3K | — | 21.3K | 1.25M | 76.88% | ↗ |
| 51 | 2015 | Pedro Lichtinger Former President and Chief Executive Officer of Asterias Biotherapeutics, Inc. | 407.0K | — | 93.3K | 524.3K | — | 9.0K | 1.03M | 59.75% | ↗ |
| 52 | 2015 | Russell L. Skibsted Chief Financial Officer | 45.0K | 8.6K | — | 899.3K | — | 1.5K | 954.4K | 94.22% | ↗ |
| 53 | 2015 | Aditya P. Mohanty Co-Chief Executive Officer | 460.4K | 250.0K | — | — | — | 13.3K | 723.7K | 0.00% | ↗ |
| 54 | 2015 | Aditya Mohanty Co-Chief Executive Officer | 460.4K | 50.0K | 200.0K | — | — | 13.3K | 723.7K | 27.64% | ↗ |
| 55 | 2014 | Pedro Lichtinger Former President and Chief | 224.4K | — | 468.0K | 1.41M | — | 8.3K | 2.11M | 88.97% | ↗ |
| 56 | 2014 | Pedro Lichtinger Former President and Chief Executive Officer of Asterias Biotherapeutics, Inc. | 224.4K | — | 468.0K | 1.41M | — | 8.3K | 2.11M | 88.97% | ↗ |
| 57 | 2014 | Michael D. West Chief Executive Officer | 680.3K | 204.0K | — | 624.1K | — | 38.0K | 1.55M | 40.36% | ↗ |
| 58 | 2014 | Michael D. West Co-Chief Executive Officer | 680.3K | 204.0K | — | 624.1K | — | 38.0K | 1.55M | 40.36% | ↗ |
| 59 | 2014 | Aditya Mohanty Co-Chief Executive Officer | 5.2K | — | — | 1.49M | — | — | 1.50M | 99.65% | ↗ |
| 60 | 2014 | Robert W. Peabody Former Senior Vice-President, and Chief Financial Officer | 430.1K | 107.5K | — | 237.7K | — | 13.0K | 788.3K | 30.15% | ↗ |
| 61 | 2014 | Robert W. Peabody Senior Vice-President, Chief Operating Officer, and Chief Financial Officer | 430.1K | 107.5K | — | 237.7K | — | 13.0K | 788.3K | 30.15% | ↗ |
| 62 | 2014 | William P. Tew Chief Commercial Officer | 343.3K | — | — | 190.3K | — | 13.0K | 546.6K | 34.82% | ↗ |
| 63 | 2014 | Lesley A. Stolz Executive Vice President, Corporate Development | 76.2K | — | — | 95.2K | — | — | 171.3K | 55.55% | ↗ |
| 64 | 2013 | Michael D. West Co-Chief Executive Officer | 680.3K | 65.0K | — | 851.6K | — | 37.8K | 1.63M | 52.10% | ↗ |
| 65 | 2013 | Michael D. West Chief Executive Officer | 680.3K | 65.0K | — | 851.6K | — | 37.8K | 1.63M | 52.10% | ↗ |
| 66 | 2013 | Robert W. Peabody Senior Vice-President, Chief Operating Officer, and Chief Financial Officer | 405.1K | 145.0K | — | 521.5K | — | 12.0K | 1.08M | 48.13% | ↗ |
| 67 | 2013 | Robert W. Peabody Senior Vice-President, Chief Financial Officer | 405.1K | 145.0K | — | 521.5K | — | 12.0K | 1.08M | 48.13% | ↗ |
| 68 | 2013 | Robert W. Peabody Former Senior Vice-President, and Chief Financial Officer | 405.1K | 145.0K | — | 521.5K | — | 12.0K | 1.08M | 48.13% | ↗ |
| 69 | 2013 | Lesley A. Stolz Executive Vice President, Corporate Development | 104.2K | — | — | 591.3K | — | — | 695.5K | 85.02% | ↗ |
| 70 | 2013 | Lesley A. Stolz Executive Vice President, Corporate Development | 104.2K | — | — | 591.3K | — | — | 695.5K | 85.02% | ↗ |
| 71 | 2013 | Peter S. Garcia Chief Financial Officer | 154.7K | — | — | 520.8K | — | 12.7K | 688.2K | 75.67% | ↗ |
| 72 | 2013 | William P. Tew Chief Commercial Officer | 285.0K | 30.0K | — | 343.3K | — | 12.8K | 671.0K | 51.16% | ↗ |
| 73 | 2012 | Michael D. West Chief Executive Officer | 660.5K | 100.0K | — | — | — | 24.5K | 785.0K | 0.00% | ↗ |
| 74 | 2012 | Robert W. Peabody Senior Vice-President, Chief Operating Officer, and Chief Financial Officer | 386.9K | 45.0K | — | — | — | 12.5K | 444.4K | 0.00% | ↗ |
| 75 | 2012 | Robert W. Peabody Senior Vice-President, and Chief Financial Officer | 386.9K | 45.0K | — | — | — | 12.5K | 444.4K | 0.00% | ↗ |
| 76 | 2012 | Robert W. Peabody Senior Vice-President, Chief Financial Officer | 386.9K | 45.0K | — | — | — | 12.5K | 444.4K | 0.00% | ↗ |
| 77 | 2012 | Peter S. Garcia Chief Financial Officer | 324.0K | 100.0K | — | — | — | 12.5K | 436.5K | 0.00% | ↗ |
| 78 | 2012 | William Tew Chief Commercial Officer | 237.5K | 20.0K | — | — | — | 11.1K | 268.6K | 0.00% | ↗ |
| 79 | 2012 | William P. Tew Chief Commercial Officer | 237.5K | 20.0K | — | — | — | 11.1K | 268.6K | 0.00% | ↗ |
| 80 | 2011 | Michael D. West Chief Executive Officer | 560.5K | 266.0K | — | 10.7K | — | 19.0K | 856.2K | 1.25% | ↗ |
| 81 | 2011 | Peter S. Garcia Chief Financial Officer | 81.0K | 6.0K | — | 703.2K | — | 3.5K | 793.7K | 88.60% | ↗ |
| 82 | 2011 | Peter S. Garcia Chief Financial Officer | 81.0K | 6.0K | — | 703.2K | — | 3.5K | 793.7K | 88.60% | ↗ |
| 83 | 2011 | Robert W. Peabody Senior Vice-President, and Chief Financial Officer | 336.9K | 156.0K | — | 5.3K | — | 12.5K | 510.7K | 1.04% | ↗ |
| 84 | 2011 | Robert W. Peabody Senior Vice-President, Chief Operating Officer | 336.9K | 156.0K | — | 5.3K | — | 12.5K | 510.7K | 1.04% | ↗ |
| 85 | 2011 | Robert W. Peabody Senior Vice-President, Chief Financial Officer | 336.9K | 156.0K | — | 5.3K | — | 12.5K | 510.7K | 1.04% | ↗ |
| 86 | 2011 | William Tew Chief Commercial Officer | 145.0K | 26.0K | — | 177.1K | — | 7.3K | 355.4K | 49.83% | ↗ |
| 87 | 2011 | William Tew Chief Commercial Officer | 145.0K | 26.0K | — | 177.1K | — | 7.3K | 355.4K | 49.83% | ↗ |
| 88 | 2011 | Walter Funk Vice-President of Stem Cell Technology | 154.5K | 1.0K | — | — | — | — | 155.5K | 0.00% | ↗ |
| 89 | 2010 | Michael D. West Chief Executive Officer | 350.0K | 215.8K | — | — | — | 16.5K | 589.2K | 0.00% | ↗ |
| 90 | 2010 | Robert W. Peabody Senior Vice-President, Chief Operating Officer | 230.0K | 105.8K | — | 3.5K | — | 11.5K | 350.7K | 0.99% | ↗ |
| 91 | 2010 | Robert W. Peabody Senior Vice-President, and Chief Financial Officer | 230.0K | 105.8K | — | 3.5K | — | 11.5K | 350.7K | 0.99% | ↗ |
| 92 | 2010 | Robert W. Peabody Senior Vice-President, Chief Operating Officer, and Chief Financial Officer | 230.0K | 105.8K | — | — | — | 11.5K | 347.3K | 0.00% | ↗ |
| 93 | 2010 | Walter Funk Vice-President of Stem Cell Technology | 150.0K | 2.8K | — | — | — | — | 152.8K | 0.00% | ↗ |
| 94 | 2010 | Steven Seinberg Former Chief Financial Officer | 85.0K | 5.0K | — | — | — | — | 90.0K | 0.00% | ↗ |
| 95 | 2009 | Walter Funk Vice-President of Stem Cell Technology | 62.5K | 2.3K | — | 932.5K | — | — | 997.3K | 93.51% | ↗ |
| 96 | 2009 | Vice-President of Stem Cell Research | 62.5K | 2.3K | — | 932.5K | — | — | 997.3K | 93.51% | ↗ |
| 97 | 2009 | Michael D. West Chief Executive Officer | 258.3K | 87.9K | — | — | — | 24.3K | 372.6K | 0.00% | ↗ |
| 98 | 2009 | Robert W. Peabody Senior Vice-President, Chief Operating Officer, and Chief Financial Officer | 165.8K | 58.5K | — | — | — | 11.2K | 235.6K | 0.00% | ↗ |
| 99 | 2009 | Robert W. Peabody Senior Vice-President and Chief Operating Officer | 165.8K | 58.5K | — | — | — | 11.2K | 235.6K | 0.00% | ↗ |
| 100 | 2009 | Robert W. Peabody Senior Vice-President, Chief Operating Officer | 165.8K | 58.5K | — | — | — | 11.2K | 235.6K | 0.00% | ↗ |
| 101 | 2009 | Hal Sternberg Vice-President of Research | 101.7K | 12.3K | — | — | — | 1.3K | 115.2K | 0.00% | ↗ |
| 102 | 2009 | Steven Seinberg Former Chief Financial Officer | 78.3K | 750.00 | — | — | — | — | 79.1K | 0.00% | ↗ |
| 103 | 2008 | Michael D. West Chief Executive Officer | 250.0K | — | — | — | — | 24.3K | 274.5K | 0.00% | ↗ |
| 104 | 2008 | Robert W. Peabody Senior Vice-President, Chief Operating Officer, and Chief Financial Officer | 160.0K | — | — | — | — | 8.0K | 168.0K | 0.00% | ↗ |
| 105 | 2008 | Senior Vice President and Chief Operating Officer | 160.0K | — | — | — | — | — | 168.0K | 0.00% | ↗ |
| 106 | 2008 | Robert W. Peabody Senior Vice-President and Chief Operating Officer | 160.0K | — | — | — | — | 8.0K | 168.0K | 0.00% | ↗ |
| 107 | 2008 | Hal Sternberg Vice-President of Research | 80.0K | — | — | — | — | — | 80.0K | 0.00% | ↗ |
| 108 | 2008 | Steven Seinberg Former Chief Financial Officer | 80.0K | — | — | — | — | — | 80.0K | 0.00% | ↗ |
| 109 | 2007 | Michael D. West Chief Executive Officer | 62.5K | — | — | — | — | — | 72.3K | 0.00% | ↗ |
| 110 | 2007 | Senior Vice President and Chief Operating Officer | 40.0K | — | — | — | — | — | 43.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Brian Culley | Chief Executive Officer, President & Director | 1M | male |
| Jill Ann Howe | Chief Financial Officer | 718.0K | female |
| George A. Samuel | General Counsel & Company Secretary | 690.3K | male |
| Brandi L. Roberts | Consultant | 407.5K | female |
| Harold D. Waitz | Vice President of Regulatory Affairs & Quality Control | 90.0K | — |
| Rami Skaliter | Chief Executive Officer of Cell Cure Neurosciences | — | — |
| Charlotte Hubbert | Vice President of Corporate Strategy & Development | — | — |
| Ioana C. Hone | Director of Investor Relations | — | female |
| Priyantha Herath | Senior VP & Head of Clinical Operations | — | — |
| Alexandra Hernandez | Senior Director of Finance & Controller | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-01-02 | 2024-01-29 | Anna Paulina Luna | FL13 | — | Sale | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LCTX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
